MiR-204 is known as a tumor suppressor that targets multiple oncogenes, including MYCN, BCL2, NTRK2 and PHOX2B, which are associated with tumor progression and chemoresistance in NB [114,115,116]. The gene discussed is BCL2; the disease is neoplasm.